Kokal W A, Gardine R L, Sheibani K, Zak I W, Beatty J D, Riihimaki D U, Wagman L D, Terz J J
Department of General Oncologic Surgery, City of Hope National Medical Center, Duarte, California 91010.
Am J Surg. 1988 Oct;156(4):276-80. doi: 10.1016/s0002-9610(88)80291-5.
Our purpose in this study was to determine whether tumor DNA content is a prognostic factor independent of other standard clinical and histologic parameters in squamous cell carcinoma (SCC) of the head and neck region. Tumor DNA content was determined in 76 patients with primary resectable SCC of the oral cavity, larynx, or pharynx who were treated from 1978 to 1984 at the City of Hope. In addition, we measured various clinical and pathologic parameters in all patients. In comparison to patients with diploid SCC, those with aneuploid SCC had significantly decreased relapse-free and overall survival rates (p less than 0.001 for both). A Cox regression analysis demonstrated that tumor DNA content was a prognostic factor independent of all clinicopathologic features examined. By regression analysis, it was the single most important prognostic factor in determining relapse and death from SCC (p less than 0.001 for both).
我们开展这项研究的目的是确定在头颈部鳞状细胞癌(SCC)中,肿瘤DNA含量是否为独立于其他标准临床和组织学参数的预后因素。对1978年至1984年在希望之城接受治疗的76例患有口腔、喉或咽原发性可切除SCC的患者测定了肿瘤DNA含量。此外,我们测量了所有患者的各种临床和病理参数。与二倍体SCC患者相比,非整倍体SCC患者的无复发生存率和总生存率显著降低(两者p均小于0.001)。Cox回归分析表明,肿瘤DNA含量是独立于所检查的所有临床病理特征的预后因素。通过回归分析,它是决定SCC复发和死亡的唯一最重要的预后因素(两者p均小于0.001)。